Gamida Cell is the leader in pioneering NAM-enabled cell therapies designed as a curative approach for patients with blood cancers and other serious diseases.
We are harnessing the power of our proprietary NAM-enabled technology to allogeneic cell sources including umbilical cord blood-derived cells and NK cells to create cell therapy candidates
with potential to redefine standards of care and significantly improve patient outcomes and health equity